PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
377.61%
10Y revenue/share CAGR above 1.5x XRF.AX's 172.90%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-7.19%
Negative 5Y CAGR while XRF.AX stands at 117.07%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
58.01%
3Y revenue/share CAGR at 50-75% of XRF.AX's 87.19%. Martin Whitman would question if the firm lags behind competitor innovations.
440.27%
10Y OCF/share CAGR above 1.5x XRF.AX's 256.28%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-9.19%
Negative 5Y OCF/share CAGR while XRF.AX is at 122.59%. Joel Greenblatt would question the firm’s operational model or cost structure.
32.36%
3Y OCF/share CAGR under 50% of XRF.AX's 81.61%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
525.64%
Net income/share CAGR above 1.5x XRF.AX's 298.65% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
33.58%
Below 50% of XRF.AX's 302.19%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
2633.13%
3Y net income/share CAGR above 1.5x XRF.AX's 56.14%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
1810.25%
10Y equity/share CAGR above 1.5x XRF.AX's 83.30%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
122.58%
5Y equity/share CAGR above 1.5x XRF.AX's 57.29%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
86.61%
3Y equity/share CAGR above 1.5x XRF.AX's 36.75%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.20%
Debt growth of 21.20% while XRF.AX is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.